21 March 2018
Hotel Steigenberger Wiltcher’s, Avenue Louise 71
The current debate on the next EU Framework Programme for Research and Innovation (FP9) offers the opportunity to articulate a long-term vision for biomedical and health research, and to address current gaps in support of excellent science. Developing such a vision for Europe is important to make sure that future research will continue to improve citizens’ health and quality of life.
To contribute to this debate, the FEAM European Biomedical Policy Forum’s annual lecture will bring together policy-makers and high-level representatives from across different biomedical sectors to present their vision for the future of biomedical and health research in Europe, and how the European Union’s funding programmes could help achieving this. In particular, the following topics will be addressed:
The annual lecture will feature the participation of Dr. Line Mathiessen, Acting Director at the Health Directorate of the European Commission’s Directorate-General for Research and Innovation, and of high-level representatives from academia, patients’ organisations and industry.
The FEAM European Biomedical Policy Forum provides a platform for discussion on key policy issues for the biomedical community.
The Forum is an initiative from the Federation of European Academies of Medicine (FEAM). It aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups.
If you have any questions about the event, please send an e-mail to: Silvia Bottaro, FEAM Forum Policy Officer email@example.com